20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Positron Emission Tomography studies with [ 11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Molecular imaging of the 18 kD Translocator protein (TSPO) with positron emission tomography (PET) is of great value for studying neuroinflammation in rodents longitudinally. Quantification of the TSPO in rodents is, however, quite challenging. There is no suitable reference region and the use of plasma-derived input is not an option for longitudinal studies. The aim of this study was therefore to evaluate the use of the standardized uptake value (SUV) as an outcome measure for TSPO imaging in rodent brain PET studies, using [ 11C]PBR28. In the first part of the study, healthy male Wistar rats (n = 4) were used to determine the correlation between the distribution volume (V T, calculated with Logan graphical analysis) and the SUV. In the second part, healthy male Wistar rats (n = 4) and healthy male C57BL/6J mice (n = 4), were used to determine the test-retest variability of the SUV, with a 7-day interval between measurements. Dynamic PET scans of 63 minutes were acquired with a nanoScan PET/MRI and nanoScan PET/CT. An MRI scan was made for anatomical reference with each measurement. The whole brain V T of [ 11C]PBR28 in rats was 42.9 ± 1.7. A statistically significant correlation (r 2 = 0.96; p < 0.01) was found between the V T and the SUV. The test-retest variability in 8 brain region ranged from 8 to 20% in rats and from 7 to 23% in mice. The interclass correlation coefficient (ICC) was acceptable to excellent for rats, but poor to acceptable for mice. In conclusion: The SUV of [ 11C]PBR28 showed a high correlation with V T as well as good test-retest variability. For future longitudinal small animal PET studies the SUV can thus be used to describe [ 11C]PBR28 uptake in healthy brain tissue. Based on the present observations, further studies are needed to explore the applicability of this approach in small animal disease models, with special regard to neuroinflammatory models.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: not found

          In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

          Neuroinflammation is a pathological hallmark of Alzheimer's disease, but its role in cognitive impairment and its course of development during the disease are largely unknown. To address these unknowns, we used positron emission tomography with (11)C-PBR28 to measure translocator protein 18 kDa (TSPO), a putative biomarker for inflammation. Patients with Alzheimer's disease, patients with mild cognitive impairment and older control subjects were also scanned with (11)C-Pittsburgh Compound B to measure amyloid burden. Twenty-nine amyloid-positive patients (19 Alzheimer's, 10 mild cognitive impairment) and 13 amyloid-negative control subjects were studied. The primary goal of this study was to determine whether TSPO binding is elevated in patients with Alzheimer's disease, and the secondary goal was to determine whether TSPO binding correlates with neuropsychological measures, grey matter volume, (11)C-Pittsburgh Compound B binding, or age of onset. Patients with Alzheimer's disease, but not those with mild cognitive impairment, had greater (11)C-PBR28 binding in cortical brain regions than controls. The largest differences were seen in the parietal and temporal cortices, with no difference in subcortical regions or cerebellum. (11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule. (11)C-PBR28 binding also inversely correlated with grey matter volume. Early-onset (<65 years) patients had greater (11)C-PBR28 binding than late-onset patients, and in parietal cortex and striatum (11)C-PBR28 binding correlated with lower age of onset. Partial volume corrected and uncorrected results were generally in agreement; however, the correlation between (11)C-PBR28 and (11)C-Pittsburgh Compound B binding was seen only after partial volume correction. The results suggest that neuroinflammation, indicated by increased (11)C-PBR28 binding to TSPO, occurs after conversion of mild cognitive impairment to Alzheimer's disease and worsens with disease progression. Greater inflammation may contribute to the precipitous disease course typically seen in early-onset patients. (11)C-PBR28 may be useful in longitudinal studies to mark the conversion from mild cognitive impairment or to assess response to experimental treatments of Alzheimer's disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Graphical analysis of PET data applied to reversible and irreversible tracers.

            Jean Logan (2000)
            The differential equations of compartmental analysis form the basis of the models describing the uptake of tracers used in imaging studies. Graphical analyses convert the model equations into linear plots, the slopes of which represent measures of tracer binding. The graphical methods are not dependent upon a particular model structure but the slopes can be related to combinations of the model parameters if a model structure is assumed. The input required is uptake data from a region of interest vs time and an input function that can either be plasma measurements or uptake data from a suitable reference region. Graphical methods can be applied to both reversible and irreversibly binding tracers. They provide considerable ease of computation compared to the optimization of individual model parameters in the solution of the differential equations generally used to describe the binding of tracers. Conditions under which the graphical techniques are applicable and some problems encountered in separating tracer delivery and binding are considered. Also the effect of noise can introduce a bias in the distribution volume which is the slope of the graphical analysis of reversible tracers. Smoothing techniques may minimize this problem and retain the model independence. In any case graphical techniques can provide insight into the binding kinetics of tracers in a visual way.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

              Microglia constitute the primary resident immune surveillance cell in the brain and are thought to play a significant role in the pathogenesis of several neurodegenerative disorders, such as Alzheimer's disease, multiple sclerosis, Parkinson's disease and HIV-associated dementia. Measuring microglial activation in vivo in patients suffering from these diseases may help chart progression of neuroinflammation as well as assess efficacy of therapies designed to modulate neuroinflammation. Recent studies suggest that activated microglia in the CNS may be detected in vivo using positron emission tomography (PET) utilizing pharmacological ligands of the mitochondrial peripheral benzodiazepine receptor (PBR (recently renamed as Translocator protein (18kDa)). Beginning with the molecular characterization of PBR and regulation in activated microglia, we examine the rationale behind using PBR ligands to image microglia with PET. Current evidence suggests these findings might be applied to the development of clinical assessments of microglial activation in neurological disorders.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                21 May 2015
                2015
                : 10
                : 5
                : e0125917
                Affiliations
                [1 ]Department of Clinical Neuroscience, Karolinska Institutet, Centrum for Psychiatry Research, Stockholm, Sweden
                [2 ]Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
                [3 ]Imperial College—NTU, Lee Chian Kong School of Medicine, Nanyang Technological University, Singapore
                Chiba University Center for Forensic Mental Health, JAPAN
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Conceived and designed the experiments: MT JD JH AV CH BG. Performed the experiments: MT JD NA. Analyzed the data: MT JD NA. Contributed reagents/materials/analysis tools: CH BG. Wrote the paper: MT JD JH AV NA CH BG.

                Article
                PONE-D-14-55372
                10.1371/journal.pone.0125917
                4440816
                25996996
                56e12142-4958-4390-ba71-1a8e76656e6f
                Copyright @ 2015

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

                History
                : 10 December 2014
                : 26 March 2015
                Page count
                Figures: 6, Tables: 2, Pages: 14
                Funding
                CH, BG, and MT received funding from European Union's Seventh Framework Program FP7/2007-2013, GA 278850, Imaging of Neuroinflammation in Neurodegenerative Diseases ( http://www.uni-muenster.de/InMind/). CH and BG recieved funding from European Cooperation in Science and Technology COST Action TD1007 ( http://www.pet-mri.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Custom metadata
                According to Swedish regulations: Data can only be exported to a researcher (I) for the purpose of research and (II) after ethics approval, provided that it is beyond doubt that no one is harmed. Deposition of data in an open depository where other people, without control, can access the data MAY result in harm. Hence, researchers/universities are not allowed to deposit their data in public repositories according to the Swedish Secrecy Act 24:8. The data underlying this paper are available upon request to the corresponding author, pending ethical approval.

                Uncategorized
                Uncategorized

                Comments

                Comment on this article